comparemela.com

Page 8 - Mara Goldstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

VSTM Stock, A Top 8% Stock, Rockets On Excitement In Ovarian Cancer Treatment

Verastem could be angling for an accelerated approval of its ovarian cancer treatment, an analyst said Thursday as she upgraded VSTM stock.

Verastem stock climbs as Mizuho upgrades on cancer drug data

Verastem (VSTM) added ~14% on Thursday after Mizuho upgraded the stock arguing latest data for its cancer drug avutometinib could support accelerated nod. Read more here.

vimarsana © 2020. All Rights Reserved.